Four Decades of Orphan Drugs and Priorities for the Future

By many measures, the Orphan Drug Act has been a resounding success. Yet many rare diseases still lack treatments, and some manufacturers have used the law in ways that diverge from its original intent.

​   The New England Journal of Medicine: Search Results in Hematology/Oncology

Publicaciones relacionadas

Mira también
Botón volver arriba